There is still no cure for type 1 diabetes, despite decades of research and promises. Most people with the disease say that a “cure” should mean being able to live a healthy life, free of dependence on external insulin—and without using powerful drugs that suppress the body's immune response. Only one current line of research holds real hope for both in the near term: the therapy known as encapsulated islets or the bioartificial pancreas. Hanuman Medical Foundation supports this vital research through its work with the Islet Sheet Project, a long-term collaboration by a team of leading diabetes researchers and medical inventors.
The Islet Sheet Project expects to begin clinical trials in 2013. This can be life-changing news for people with type 1 diabetes and their loved ones. We're committed to real progress, not promises. Please read on … and join us.
“We believe this technology has significant potential to be considered a ‘cure’ for type 1 diabetes.”
—The authors of Targeting a Cure for Type 1 Diabetes
NEWS
Large-Animal Trials of Islet Sheet Begin
January 17, 2012
Today the definitive large-animal study of the Islet Sheet encapsulation device kicked off with the first surgical procedure under the approved protocol. This was a practice pancreatectomy on a... READ MORE
Scott King Talks to JDCA About the Islet Sheet
December 20, 2011
The Juvenile Diabetes Cure Alliance (JDCA) blog has published an interview with Scott R. King, president of Islet Sheet Medical and co-inventor of the Islet Sheet therapy for type 1 diabetes. JDCA... READ MORE
This blog is most often authored by Scott R. King, president and founder of Islet Sheet Medical, a biotechnology company working with Hanuman Medical Foundation. Scott was diagnosed with type 1 diabetes in 1977, and since then has been devoted to understanding and ameliorating the disease. The Sheet shares updates on our work and welcomes comments.
“Glucose Responsive Insulin” Will Not Improve the Lives of Type 1 Diabetics
February 19th, 2012
I spend time studying developments in diabetes research, and when possible I like to help other diabetes decision makers with my analysis. Today I am sharing a letter I sent to the president of Juvenile Diabetes Research Fund (JDRF), Jeffrey Brewer, explaining why I think their Glucose Responsive Insulin program is highly unlikely to produce... READ MORE
Design Protocol for Large-Animal Islet Sheet Study
January 30th, 2012
My last posting marked the start of trials at the new Cedars-Sinai lab to determine the efficacy of the Islet Sheet in large mammals—a long-awaited goal. It also talked about Professor Richard Bergman’s vision for his new Diabetes and Obesity Research Institute there. The fact that Bergman, known as a leader in type 2 research,... READ MORE
Animated views of how the Islet Sheet with its encapsulated islets works
